EFFECTIVENESS OF COMPLEX PREVENTION MEASURES FOR VIRAL HEPATITIS B AND C: CLINICAL-EPIDEMIOLOGICAL DYNAMICS AND EDUCATIONAL EFFECT

Authors

  • Saidmuratov Mirzohid Abdumuratovich
  • Khomidov Firuz Kasimovich

Keywords:

hepatitis B, hepatitis C, prevention, screening, vaccination, epidemiological surveillance, immunological markers, sanitary education, epidemiology, national health program.

Abstract

Viral hepatitis B and C continue to be one of the most significant public health problems, determining the high prevalence of chronic liver diseases, cirrhosis, and hepatocellular carcinoma. Despite the implementation of the National Program of the Republic of Uzbekistan (2022-2026), a low level of public awareness, low commitment to preventive measures, and pronounced regional differences in the spread of infection persist. This study includes a comprehensive assessment of 240 respondents, including 200 patients with various forms of viral hepatitis B and C and 40 healthy individuals. Analysis of clinical-epidemiological, immunological, and socio-hygienic characteristics made it possible to identify the main barriers to prevention, identify risk factors, and assess the effectiveness of existing measures - vaccination, screening, and sanitary-educational activities. Based on the data obtained, an improved set of preventive measures has been developed, including expanding testing coverage, increasing vaccination accessibility, optimizing epidemiological surveillance, and improving sanitary literacy. The implementation of the proposed model allows predicting a decrease in morbidity by 18-22% and an increase in vaccination coverage to 85%, which confirms the high practical significance of the study.

References

Всемирная организация здравоохранения. Глобальный отчёт по гепатитам 2022. — Женева: WHO Press, 2022. — 87 с.

Магрупов Б.А., Умаров Б.Я. Эпидемиологическая ситуация и профилактика вирусных гепатитов в Узбекистане. — Ташкент: Минздрав РУз, 2023. — 152 с.

Shepard C.W., Simard E.P., Finelli L. Hepatitis B Virus Infection: Epidemiology and Vaccination. — Lancet Infectious Diseases. — 2020. — Т. 20, №4. — С. 483–497.

Stanaway J.D., Flaxman A.D. The Global Burden of Viral Hepatitis. — Clinical Liver Disease. — 2022. — Т. 19, №2. — С. 55–72.

Ott J.J., Stevens G.A., Wiersma S.T. The Epidemiology of Hepatitis B and C Worldwide. — WHO Journal. — 2021. — Т. 17, №3. — С. 72–90.

Chulanov V., Mamonova N., Poleschuk O. Hepatitis B and C Control Strategies in Eurasia. — Journal of Viral Hepatitis. — 2022. — Т. 29, №1. — С. 45–58.

Lavanchy D. Hepatitis C: Epidemiology of a Global Health Problem. — World Journal of Gastroenterology. — 2019. — Т. 25, №13. — С. 1691–1706.

Polaris Observatory. Global Prevalence and Elimination Prospects for Hepatitis C. — J. Hepatology. — 2020. — Т. 73, №6. — С. 1230–1245.

Marcellin P., Asselah T. Clinical Course and Management of Chronic Hepatitis B. — Journal of Hepatology. — 2019. — Т. 70, №1. — С. 13–34.

Bertoletti A., Kennedy P.T. HBV-specific Immune Response and Vaccine Implications. — Nature Reviews Immunology. — 2021. — Т. 21, №3. — С. 167–181.

Published

2026-04-13